http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100719789-B1

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D277-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D277-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D277-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-06
filingDate 2000-08-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2007-05-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2007-05-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber KR-100719789-B1
titleOfInvention Substituted benzylthiazolidine-2,4-dione derivatives
abstract The present invention provides a substituted benzylthiazolidine-2,4-dione derivative exhibiting hypoglycemic action and lipid lowering action by increasing the transcriptional activity of the receptor as a ligand of human peroxysome proliferation drug activation receptor (PPAR) and its preparation Provide a method.n n n The present invention relates to substituted benzylthiazolidine-2,4-dione derivatives of formula (1), pharmaceutically acceptable salts and hydrates thereof, and methods for their preparation.n n n Formula 1n n n n n n n n In Formula 1 above,n n n R 1 is a chlorine atom, bromine atom, nitro group, trifluoromethoxy group, ethoxy group, propoxy group or isopropoxy group,n n n R 2 is a hydrogen atom or a chlorine atom.n n n Substituted benzylthiazolidine-2,4-dione derivatives, peroxysomes, transcriptional activity, diabetes, hyperlipidemia
priorityDate 1999-08-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0846693-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465039544
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID163565527
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467002712
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467187175
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465162688
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467571644
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467571642
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID163479055

Total number of triples: 26.